Myriad Genetics, Inc.

NASDAQ:MYGN

17.67 (USD) • At close November 7, 2024
Bedrijfsnaam Myriad Genetics, Inc.
Symbool MYGN
Munteenheid USD
Prijs 17.67
Beurswaarde 1,604,796,468
Dividendpercentage 0%
52-weken bereik 16 - 29.3
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Paul J. Diaz
Website https://myriad.com

An error occurred while fetching data.

Over Myriad Genetics, Inc.

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the

Vergelijkbare Aandelen

Ironwood Pharmaceuticals, Inc. logo

Ironwood Pharmaceuticals, Inc.

IRWD

4.66 USD

PROCEPT BioRobotics Corporation logo

PROCEPT BioRobotics Corporation

PRCT

96.23 USD

Schrödinger, Inc. logo

Schrödinger, Inc.

SDGR

18.78 USD

LumiraDx Limited logo

LumiraDx Limited

LMDX

0.016 USD

Definitive Healthcare Corp. logo

Definitive Healthcare Corp.

DH

4.31 USD

Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc.

RLAY

6.14 USD

Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc.

FLGT

22.02 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)